The forecasted mortality rate for neoplasms in the U.S. from 2024 to 2028 shows a gradual decline in male deaths per hundred thousand men: from 194.8 in 2024 to 191.6 in 2028. This data suggests a year-on-year decrease of approximately 0.4-0.5%, improving the general outlook from 2023, which saw higher figures. The compound annual growth rate (CAGR) over the five-year period reveals a consistent reduction in mortality, indicating positive advances in cancer treatment and prevention.
Future trends to watch for include advancements in personalized medicine, improved early-detection technologies, and enhanced healthcare policies. These factors may continue to reduce mortality rates beyond 2028.
